Nothing Special   »   [go: up one dir, main page]

Nakai et al., 2001 - Google Patents

Preparation and characterization of SNO-PEG-hemoglobin as a candidate for oxygen transporting material

Nakai et al., 2001

Document ID
8870951011948931504
Author
Nakai K
Togashi H
Yasukohchi T
Sakuma I
Fujii S
Yoshioka M
Satoh H
Kitabatake A
Publication year
Publication venue
The International Journal of Artificial Organs

External Links

Snippet

Acellular hemoglobin (Hb) derivates developed as oxygen carriers are known to cause hypertensive reactions due to their nitric oxide (NO) scavenging action. To modulate this undesired activity, we have developed a new Hb derivative, s-nitrosylated polyethylene …
Continue reading at journals.sagepub.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41—Porphyrin- or corrin-ring-containing peptides
    • A61K38/42—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A61K38/385—Serum albumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids

Similar Documents

Publication Publication Date Title
Murphy et al. Effect of propofol and thiopentone on free radical mediated oxidative stress of the erythrocyte
JP3568541B2 (en) Treatment of hemoglobin-containing erythrocytes with nitric oxide
Everse et al. The toxicities of native and modified hemoglobins
Scorza et al. Role of ascorbate and protein thiols in the release of nitric oxide from S-nitroso-albumin and S-nitroso-glutathione in human plasma
US20090232909A1 (en) Method for determining physiological effects of hemoglobin
Nakai et al. Inhibition of endothelium-dependent relaxation by hemoglobin in rabbit aortic strips: comparison between acellular hemoglobin derivatives and cellular hemoglobins
Young et al. Toxicity and hemodynamic effects after single dose administration of MalPEG-hemoglobin (MP4) in rhesus monkeys
Cooper et al. Engineering tyrosine residues into hemoglobin enhances heme reduction, decreases oxidative stress and increases vascular retention of a hemoglobin based blood substitute
Sakai et al. Hemoglobin vesicles and red blood cells as carriers of carbon monoxide prior to oxygen for resuscitation after hemorrhagic shock in a rat model
D’Agnillo et al. Site-specific modifications and toxicity of blood substitutes: the case of diaspirin cross-linked hemoglobin
Jollow et al. Oxidative stress, glucose-6-phosphate dehydrogenase and the red cell
Lieberthal et al. O-raffinose cross-linking markedly reduces systemic and renal vasoconstrictor effects of unmodified human hemoglobin
Nagababu et al. Routes for formation of S-nitrosothiols in blood
AU2020267259A1 (en) Reduced oxygen carriers and their use for the treatment of carboxyhemoglobinemia
GREENBURG et al. Improved retention of stroma-free hemoglobin solution by chemical modification
Sonoda et al. An assay method for nitric oxide-related compounds in whole blood
Portörő et al. Towards a novel haemoglobin-based oxygen carrier: Euro-PEG-Hb, physico-chemical properties, vasoactivity and renal filtration
D’Agnillo et al. Absence of Hemoprotein-Associated Free Radical Events Following Oxidant Challenge of Crosslinked Hemoglobin–Superoxide Dismutase Catalase
Osawa et al. Differential susceptibilities of the prosthetic heme of hemoglobin-based red cell substitutes: implications in the design of safer agents
Nakai et al. Preparation and characterization of SNO-PEG-hemoglobin as a candidate for oxygen transporting material
Attia et al. Effects of antioxidant vitamins on some hemoglobin properties and erythrocytes in homozygous beta-thalassemia
Pincemail et al. Diaspirin crosslinked hemoglobin (DCLHbTM): Absence of increased free radical generation following administration in a rabbit model of renal ischemia and reperfusion
Li et al. Study on oxidation stability and oxygen affinity of hemoglobin during storage
Vrancken et al. Postprandial lipids accelerate and redirect nitric oxide consumption in plasma
HASEGAWA et al. Experimental Study on p-Chloronitrobenzene Poisoning in Rabbit Effect of p-Chloronitrobenzene upon the Oxygen Affinity of Hemoglobin